City

Bay City (1)

Detroit (1)

Scottsdale (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Barbara Ann Karmanos Cancer Institute (1)

HonorHealth Research Institute (1)

Collaborator

Merck Sharp & Dohme LLC (1)

National Cancer Institute (NCI) (1)

Salarius Pharmaceuticals, LLC (1)

Intervention

dexamethasone (1)

laboratory biomarker analysis (1)

pembrolizumab (1)

sp-2577 (1)

valproic acid (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

ovarian clear cell tumor

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

SCCOHT, Ovarian Clear Cell Tumor, Ovarian Endometrioid Adenocarcinoma Trial in Scottsdale (SP-2577, Pembrolizumab)

Withdrawn

SCCOHT
+3 more

Scottsdale, Arizona

HonorHealth Research Institute

Feb 11, 2022

Adnexal Mass, Borderline Ovarian Epithelial Tumor, Ovarian Clear Cell Tumor Trial in Bay City, Detroit (Dexamethasone,

Completed

Adnexal Mass
+6 more

Dexamethasone
+2 more

Bay City, Michigan
+1 more

Aug 12, 2019